Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
ReveloHealth has received a strategic investment from Accrete Health Partners, the digital venture arm of Bon Secours Mercy Health, to expand its iCALIBRATE platform and improve contract performance and reimbursement accuracy.
PartsSource has introduced new Asset Uptime capabilities within its PRO platform to help health systems improve visibility into equipment performance and increase clinical capacity. The new features will be demonstrated at the AAMI eXchange in Denver.
Metabolon has released the Metabolon Verus metabolomics profiling kit, enabling laboratories worldwide to perform standardized and reproducible metabolomic analyses using validated workflows and integrated bioinformatics tools.
CPC Biotech and Multiply Labs have announced a collaboration to develop robotic systems for automated cell therapy production, introducing a new aseptic connector designed for robotic operation.
The U.S. Food and Drug Administration has granted Breakthrough Device Designation to Gene Solutions' SPOT-MAS 10, a blood-based multi-cancer screening test that uses machine learning to detect cancer signals in asymptomatic adults.
Merck KGaA, Darmstadt, Germany, has chosen Veeva Vault CRM for its global operations to support data connectivity and consistent processes across its healthcare business.
Subtle Medical has received FDA clearance for SubtleHD PET, its AI-based PET image enhancement software designed to improve image quality and accelerate PET imaging workflows across PET/CT and PET/MR systems.
Researchers in Shanghai found that general practitioners could identify carotid artery plaque in high-risk patients using AI assisted portable ultrasound, though performance varied among practitioners.
A new survey by L.E.K. Consulting finds that U.S. health systems are increasingly split between financially strong and struggling organizations, with policy uncertainty, access challenges, and selective AI investment shaping future strategies.
Ember LifeSciences has added new strategic investments from Amgen Ventures and TDF Ventures, bringing its Series A funding total to $27 million. The company also announced the commercial launch of the Ember Cube 2, a reusable cold chain shipping solution with real-time monitoring and cloud tracking.
Debut and Natura have announced a partnership to commercialize an AI discovered skin longevity ingredient complex, combining Debut’s biotechnology platform with Natura’s Amazonian bioactives expertise. Products could launch as early as 2027 following clinical validation.
Brain Navi Biotechnology has introduced NaoTrac, a neurosurgical navigation robot that uses machine vision and 3D positioning to improve precision and reduce operation time in brain surgery.
Neurophet has announced a collaboration with Spain’s Vall d'Hebron Institut de Recerca to advance AI algorithms for detecting multiple sclerosis lesions using MRI data. The study will use large datasets to validate Neurophet AQUA MS, which received FDA clearance in 2024.
Insilico Medicine and Human Longevity have announced a collaboration to create a large-scale AI foundation model focused on longevity science, combining advanced multimodal modeling with extensive clinical and genomic datasets.
The Deerborne Group announced that its senior leadership will attend the American Society of Clinical Oncology 2026 Annual Meeting in Chicago, where the firm will highlight its AI-enabled COMPASS 360 platform for diagnostics strategy and decision-making.
The Parkinson's Foundation has identified over 2,000 potential participants for Neuron23's NEULARK clinical trial using its new PD Trial Navigator program, which connects genetically eligible individuals with Parkinson's disease to relevant studies.
Octagos has introduced Ask Atlas, an AI tool that enables cardiac device clinics to query their clinical, operational, and billing data using natural language. The platform, built on Atlas AI, was previewed at the Heart Rhythm Society meeting in April 2026.
Tokyo and Palo Alto-based biotechnology company bitBiome has closed an oversubscribed seed extension round, bringing its total equity and non-dilutive funding to over 45 million USD. The company plans to expand its microbial enzyme discovery and engineering platforms and strengthen its global partnerships.
Prezent Vivo and Nested Knowledge have formed a strategic partnership to deliver AI powered competitive intelligence to life sciences teams, combining communication and evidence synthesis technologies to accelerate congress preparation and ongoing insights.
Tata Elxsi has introduced ViTel, a material intelligence platform co-developed with Viridium AI to help medical device manufacturers manage sourcing, compliance, and engineering decisions through AI-powered data integration.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
